Bloodless chimeric antigen receptor (CAR) T-cell therapy in Jehovah's Witnesses

Leuk Lymphoma. 2021 Jun;62(6):1497-1501. doi: 10.1080/10428194.2021.1876868. Epub 2021 Feb 3.

Authors

Peter A Riedell^{1

2}, Meng Wu³, Jennifer M Collins⁴, Jacklyn M Gideon^{1

2}, Andrzej J Jakubowiak^{1

2}, Justin P Kline^{1

2}, Satyajit Kosuri^{1

2}, Hongtao Liu^{1

2}, Sonali M Smith¹, Michael R Bishop^{1

2}

Affiliations

¹ Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA.
² David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL, USA.
³ Department of Medicine, University of Chicago, Chicago, IL, USA.
⁴ Department of Pharmacy, University of Chicago, Chicago, IL, USA.

PMID: 33535838
DOI: 10.1080/10428194.2021.1876868

No abstract available

Publication types

Letter

MeSH terms

Cell- and Tissue-Based Therapy
Humans
Jehovah's Witnesses*
Receptors, Chimeric Antigen* / genetics

Substances

Receptors, Chimeric Antigen